Company profile for Aspen Pharmacare Holdings

Aspen API-PSE
News

DATA COMPILATION
#PharmaFlow

PharmaCompass
Related CompaniesRelated Companies

About

South African-based Aspen is a supplier of branded and generic pharmaceuticals in more than 150 countries across the world and of consumer and nutritional products in selected territories. Aspen is represented in South Africa, Australia, Hong Kong, Malaysia, Philippines, Taiwan, Japan, Kenya, Nigeria, Tanzania, Uganda, Ireland, United Arab Emirates, France, Germany, the Netherlands, Mauritius, Brazil, Mexico, Venezuela and the United States of America. Acquisitions announced in 2013 will further extend the Group’s emerging market presence to the Commonwealth of Independent States, comprising Russia and the former Soviet Republics.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Africa
Address
Address
Aspen House, Aspen Park 98 Armstrong Avenue La Lucia Ridge, Durban
Telephone
Telephone
+27 315808600
youtube
YouTube
Contact Info
Others

Events

Webinars & Exhibitions

Default Event

CPhI North America

Not Confirmed

envelop Contact Supplier

CPhI North America

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

NEWS #PharmaBuzz

read-more
read-more

https://www.reuters.com/business/healthcare-pharmaceuticals/african-drugmaker-aspen-posts-5-rise-half-year-earnings-2025-03-03/

REUTERS
05 Mar 2025
Aspen shells out $100M for Sandoz's China unit, pipeline
Aspen shells out $100M for Sandoz's China unit, pipeline

04 Dec 2023

// Zoey Becker FIERCE PHARMA

https://www.fiercepharma.com/pharma/south-africas-aspen-expands-reach-china-100m-buy-sandoz-chinese-business

Zoey Becker FIERCE PHARMA
04 Dec 2023
Novo Nordisk taps Aspen to help produce insulin for Africa
Novo Nordisk taps Aspen to help produce insulin for Africa

19 Sep 2023

// Fraiser Kansteiner FIERCE PHARMA

https://www.fiercepharma.com/pharma/following-eli-lilly-novo-nordisk-links-aspen-produce-insulin-africa

Fraiser Kansteiner FIERCE PHARMA
19 Sep 2023

https://www.aspenpharma.com/aspen-and-lilly-enter-into-agreement-in-south-africa-and-the-rest-of-sub-saharan-africa/

PRESS RELEASE
30 Aug 2023

https://www.aspenpharma.com/aspen-revenue-exceeds-r40-billion-with-accelerated-medium-term-growth-anticipated/

PRESS RELEASE
30 Aug 2023

https://www.aspenpharma.com/aspen-hosts-mandela-day-for-13th-consecutive-year-having-reached-865-000-beneficiaries/

PRESS RELEASE
18 Jul 2023

Drugs in Development

read-more
read-more

Details:

Mounjaro (tirzepatide) injection is an obesity treatment targeting GIP and GLP-1 hormone receptors. Currently it is indicated for the treatment of type 2 diabetes mellitus and obesity.


Lead Product(s): Tirzepatide

Therapeutic Area: Endocrinology Brand Name: Mounjaro

Study Phase: Approved FDFProduct Type: Peptide

Sponsor: Eli Lilly

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 20, 2024

Aspen API Comapny Banner

01

Details : Mounjaro (tirzepatide) injection is an obesity treatment targeting GIP and GLP-1 hormone receptors. Currently it is indicated for the treatment of type 2 diabetes mellitus and obesity.

Product Name : Mounjaro

Product Type : Peptide

Upfront Cash : Inapplicable

December 20, 2024

Aspen API Comapny Banner

Details:

PNEUMOSIL® (pneumococcal polysaccharide conjugate vaccine – adsorbed, 10 Valent), a well-designed vaccine, provide comparable protection by targeting the most prevalent serotypes of the bacterium causing serious illness in developing countries.


Lead Product(s): Pneumococcal Polysaccharide Conjugate Vaccine

Therapeutic Area: Infections and Infectious Diseases Brand Name: Pneumosil

Study Phase: Approved FDFProduct Type: Vaccine

Sponsor: Gates Foundation

Deal Size: $30.0 million Upfront Cash: Undisclosed

Deal Type: Funding December 12, 2022

Aspen API Comapny Banner

02

Lead Product(s) : Pneumococcal Polysaccharide Conjugate Vaccine

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Gates Foundation

Deal Size : $30.0 million

Deal Type : Funding

Details : PNEUMOSIL® (pneumococcal polysaccharide conjugate vaccine – adsorbed, 10 Valent), a well-designed vaccine, provide comparable protection by targeting the most prevalent serotypes of the bacterium causing serious illness in developing countries.

Product Name : Pneumosil

Product Type : Vaccine

Upfront Cash : Undisclosed

December 12, 2022

Aspen API Comapny Banner

Details:

PNEUMOSIL® (Pneumococcal Conjugate Vaccine – adsorbed, 10 Valent), a well-designed vaccine with relevant serotypes, provide comparable protection by targeting the most prevalent serotypes of the bacterium causing serious illness in developing countries.


Lead Product(s): 10-Valent Pneumococcal Polysaccharide Conjugate Vaccine

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Approved FDFProduct Type: Vaccine

Sponsor: Serum Institute of India

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration August 31, 2022

Aspen API Comapny Banner

03

Lead Product(s) : 10-Valent Pneumococcal Polysaccharide Conjugate Vaccine

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Serum Institute of India

Deal Size : Undisclosed

Deal Type : Collaboration

Details : PNEUMOSIL® (Pneumococcal Conjugate Vaccine – adsorbed, 10 Valent), a well-designed vaccine with relevant serotypes, provide comparable protection by targeting the most prevalent serotypes of the bacterium causing serious illness in developing countrie...

Product Name : Undisclosed

Product Type : Vaccine

Upfront Cash : Undisclosed

August 31, 2022

Aspen API Comapny Banner

Details:

EIKANCE (atropine sulfate monohydrate eye drops) are available on prescription for children aged 4 to 14 years, as a treatment to slow the progression of myopia and may be initiated in children when myopia progresses by 1 or more diopters per year.


Lead Product(s): Atropine Sulfate

Therapeutic Area: Ophthalmology Brand Name: Eikance

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 18, 2022

Aspen API Comapny Banner

04

Details : EIKANCE (atropine sulfate monohydrate eye drops) are available on prescription for children aged 4 to 14 years, as a treatment to slow the progression of myopia and may be initiated in children when myopia progresses by 1 or more diopters per year.

Product Name : Eikance

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

March 18, 2022

Aspen API Comapny Banner

Details:

Debiopharm to enter into this new alliance with Aspen, a well-established and trusted pharmaceutical partner for the commercialization of Trelstar® in South Africa and recognize the therapeutic benefits that Trelstar® could bring to prostate cancer patients in this region.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Oncology Brand Name: Trelstar

Study Phase: Approved FDFProduct Type: Hormone

Sponsor: Debiopharm

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership January 02, 2022

Aspen API Comapny Banner

05

Details : Debiopharm to enter into this new alliance with Aspen, a well-established and trusted pharmaceutical partner for the commercialization of Trelstar® in South Africa and recognize the therapeutic benefits that Trelstar® could bring to prostate cancer pat...

Product Name : Trelstar

Product Type : Hormone

Upfront Cash : Undisclosed

January 02, 2022

Aspen API Comapny Banner

Details:

The license under discussion would enable Aspen, using COVID-19 vaccine JNJ-78436735, drug substance supplied by Johnson & Johnson, to produce Aspen-branded finished vaccine for sale to public sector markets in Africa.


Lead Product(s): Ad26.COV2.S

Therapeutic Area: Infections and Infectious Diseases Brand Name: JNJ-78436735

Study Phase: Approved FDFProduct Type: Vaccine

Sponsor: Johnson & Johnson

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement November 30, 2021

Aspen API Comapny Banner

06

Details : The license under discussion would enable Aspen, using COVID-19 vaccine JNJ-78436735, drug substance supplied by Johnson & Johnson, to produce Aspen-branded finished vaccine for sale to public sector markets in Africa.

Product Name : JNJ-78436735

Product Type : Vaccine

Upfront Cash : Undisclosed

November 30, 2021

Aspen API Comapny Banner

Details:

The transaction includes Trustan, Altosec, Zuvamor, Ciavor, Grantryl and Aspen Granisetron brands. To secure uninterrupted patient access to these medicines, the parties have also signed a manufacturing and supply agreement.


Lead Product(s): Esomeprazole Magnesium

Therapeutic Area: Gastroenterology Brand Name: Trustan

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Acino Pharma

Deal Size: $119.4 million Upfront Cash: Undisclosed

Deal Type: Acquisition October 22, 2021

Aspen API Comapny Banner

07

Details : The transaction includes Trustan, Altosec, Zuvamor, Ciavor, Grantryl and Aspen Granisetron brands. To secure uninterrupted patient access to these medicines, the parties have also signed a manufacturing and supply agreement.

Product Name : Trustan

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

October 22, 2021

Aspen API Comapny Banner

Details:

Avion Pharmaceuticals gets exclusive rights to relaunch Cenestin® in the USA. Cenestin® is the only plant-derived mixture of nine conjugated estrogens indicated for treatment of moderate to severe symptoms of vasomotor, and vulvar and vaginal atrophy due to menopause.


Lead Product(s): Conjugated Estrogens

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Cenestin

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Avion Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership December 11, 2020

Aspen API Comapny Banner

08

Details : Avion Pharmaceuticals gets exclusive rights to relaunch Cenestin® in the USA. Cenestin® is the only plant-derived mixture of nine conjugated estrogens indicated for treatment of moderate to severe symptoms of vasomotor, and vulvar and vaginal atrophy d...

Product Name : Cenestin

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

December 11, 2020

Aspen API Comapny Banner

Details:

The agreement aims to manufacture and make available Aspenovax, an Aspen-branded COVID-19 vaccine, across Africa.


Lead Product(s): COVID-19 Vaccine

Therapeutic Area: Infections and Infectious Diseases Brand Name: Aspenovax

Study Phase: Approved FDFProduct Type: Vaccine

Sponsor: Johnson & Johnson Innovative Medicine

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement September 08, 2020

Aspen API Comapny Banner

09

Lead Product(s) : COVID-19 Vaccine

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Johnson & Johnson Innovative Medicine

Deal Size : Undisclosed

Deal Type : Agreement

Details : The agreement aims to manufacture and make available Aspenovax, an Aspen-branded COVID-19 vaccine, across Africa.

Product Name : Aspenovax

Product Type : Vaccine

Upfront Cash : Undisclosed

September 08, 2020

Aspen API Comapny Banner

Details:

Under the terms of the agreement, Mylan Ireland Limited will acquire the commercialisation rights and related intellectual property relating to Aspen’s Thrombosis Business in Europe which includes Arixtra, Fraxiparine, Mono-Embolex and Orgaran.


Lead Product(s): Fondaparinux Sodium

Therapeutic Area: Hematology Brand Name: Arixtra

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Viatris

Deal Size: $757.2 million Upfront Cash: $310.4 million

Deal Type: Acquisition August 09, 2020

Aspen API Comapny Banner

10

Details : Under the terms of the agreement, Mylan Ireland Limited will acquire the commercialisation rights and related intellectual property relating to Aspen’s Thrombosis Business in Europe which includes Arixtra, Fraxiparine, Mono-Embolex and Orgaran.

Product Name : Arixtra

Product Type : Other Small Molecule

Upfront Cash : $310.4 million

August 09, 2020

Aspen API Comapny Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

02

Brand Name : CYCLESSA

Aspen Pharmacare Holdings

Dosage Form : TABLET; ORAL-28

Proprietary Name : CYCLESSA

Dosage Strength : 0.1MG,0.125MG,0.15MG;0.0...

Approval Date : 2000-12-20

Application Number : 21090

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Aspen API Comapny Banner

08

Brand Name : HEXADROL

Aspen Pharmacare Holdings

Dosage Form : INJECTABLE; INJECTION

Proprietary Name : HEXADROL

Dosage Strength : EQ 4MG PHOSPHATE/ML **Fe...

Approval Date : 1982-01-01

Application Number : 14694

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Aspen API Comapny Banner

09

Brand Name : HEXADROL

Aspen Pharmacare Holdings

Dosage Form : INJECTABLE; INJECTION

Proprietary Name : HEXADROL

Dosage Strength : EQ 10MG PHOSPHATE/ML **F...

Approval Date : 1982-01-01

Application Number : 14694

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Aspen API Comapny Banner
click full view

Inspections and registrations

Check the inspections & registration from this company

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty